CAMBRIDGE, Mass.--(BUSINESS WIRE)--Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that Mark Leuchtenberger, President and Chief Executive Officer of Targanta, will present at the Canaccord Adams Anti-Infectives Investment Conference on Tuesday, September 16, 2006 at 1:45 pm Eastern Time at The InterContinental Barclay Hotel in New York, NY.
